Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

6.53
Delayed Data
As of 4:00pm ET
 -0.09 / -1.36%
Today’s Change
4.25
Today|||52-Week Range
13.71
-25.03%
Year-to-Date
Biotechs Rise and Oil Falls
Aug 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.62
Today’s open6.66
Day’s range6.43 - 6.66
Volume108,197
Average volume (3 months)230,285
Market cap$381.1M
Dividend yield--
Data as of 4:00pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+4.62%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+20.00%
P/E ratioNM
Price/Sales70.04
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp-0.04-5.53%
VSARVersartis Inc+0.33+2.60%
OMEDOncoMed Pharmaceutic...+0.12+1.16%
TRVNTrevena Inc-0.07-0.99%
Data as of 4:00pm ET, 08/29/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$4.6M
Annual profit (last year)-$45.8M
Net profit margin-998.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Operating Officer &
Executive Vice President
Jeffrey Su
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs